ÂÜÀòÂÒÂ×

Xiaohui Yu currently serves as a Clinical Consultant and previously held roles as Clinical Trial Manager and Senior Clinical Research Associate at 89bio since January 2022. Prior experience includes positions as Sr CRA/Lead Expert CRA, CRA II/Lead Expert CRA, and CRA I at IQVIA from May 2019 to January 2022, as well as Clinical Research Coordinator at Dana-Farber Cancer Institute from September 2018 to May 2019. Earlier in career, Xiaohui Yu worked as a Medical Interpreter at ARCH Language Network from June 2014 to May 2017. Xiaohui Yu is pursuing a Doctor of Philosophy (PhD) at USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences as of 2023, holding a Master of Science (MS) in Epidemiology from Harvard T.H. Chan School of Public Health (2017-2019) and a Bachelor of Nursing from the University of Minnesota School of Nursing (2013-2017).